FORMATEC Introduces The Next Generation Of Inhalers

07/04/06 RPC Formatec has launched new nasal and pulmonary drug delivery devices − the PowderJet® and the PulmoJet® − that represent a significant advance in inhaler technology. Both deliver an economic alternative to established formats − respectively, the wet nasal sprayer and the Metered Dose Inhaler (MDI) − whilst providing the features of a modern dry powder system.

The PowderJet® is a multi−dose nasal drug delivery device designed to efficiently disperse a metered dose of dry powder. It ensures effective delivery of drugs to the nasal cavity and/or the nasopharynx, with a powder dispersion profile that can be adjusted to customer requirements.

The PowderJet® is easy to use, offering an innovative metering and ejection mechanism with automatic recharging. Conforming to both EU and US dose content uniformity requirements, the PowderJet® offers up to 250 single doses depending on the product.

The PulmoJet® is a breath−actuated multi−dose dry powder inhaler with a unique dosing mechanism. Its unique air flow design ensures an optimal dispersion of the powder with minimal inhalation force by the user.

The device is designed for ease of use, with a simple open−inhale−close procedure that does not require the user to be upright. A successful inhalation is confirmed by audible and tactile signals. The system recharges automatically by unscrewing the cap. Further convenience is provided by an integrated dose counter.

RPC Formatec has designed a number of features to maintain product integrity and ensure user safety. The powder reservoir is hermetically sealed to offer the highest moisture barrier.

Furthermore, the actuation mechanism is resistant to shock and vibration. A security system prevents double dose loading during the recharging process.

The disposable inhaler is compatible with high and low dose compounds and meets both

EU and US dose uniformity requirements.